from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1311/atpC

LFCtreatmentdescriptionclass of inhibitor

-1.975

Amikacinug/mL Amikacintranslation

-3.161

Cap5-10ug/mL Capreomycintranslation

-3.677

Rox10-50 ug/mL Roxithromycintranslation

-0.451

SM2-5 ug/mL Streptomycintranslation

-3.966

Tet5-10 ug/mL Tetracyclinetranslation

-0.092

Rif0.2-5ug/mL Rifampicintranscription

-0.033

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.079

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.185

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.235

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.097

Clofazimine10-13 ug/mL Clofaziminerespiration

0.510

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.111

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.038

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.088

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.578

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.043

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.644

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.714

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.367

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.002

KCN5-20 ug/mL Potassium cyaniderespiration

1.049

NaN30.2-2 mM Sodium aziderespiration

0.354

Nigericin50 uM Nigericinrespiration

-0.658

TRC10-150 ug/mL Triclosanrespiration

-0.443

TRZ10-25 ug/mL Thioridazinerespiration

-1.934

Valinomycin0.5-10 uM Valinomycinrespiration

1.021

ZnSO42 mM ZnSO4respiration

-0.712

menadione6-10 ug/mL Menadionerespiration

0.390

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.321

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.692

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.629

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.819

NRP_1Non-replicating persistence stage 1dosRassociated

0.788

Amp0.2mg/mL AmpicillincellWall

0.584

Cephalexin20-100 ug/mL CephalexincellWall

0.080

Cerulenin0.32-5 ug/mL CerulenincellWall

0.369

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.086

EMB10-20 ug/mL EthambutolcellWall

0.553

Eta12-40 ug/mL EthionamidecellWall

0.702

INH0.2-0.4 ug/mL IsoniazidcellWall

1.107

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.481

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.603

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.115

BZA0.12 mg/mL BenzamidearomaticAmides

-0.252

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.343

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.354

H2O24 mM hydrogen peroxideDNAdamaging

-0.955

Levo10 ug/mL LevofloxacinDNAdamaging

0.567

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.441

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.035

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.033

UVUV-irradiationDNAdamaging

-0.152

ARP41-4 ug/mL Antitubercular compound ARP4?

0.639

Antimycin12.5-50 ug/mL Antimycin A?

0.441

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.218

PA_110-50 ug/mL Antitubercular compound PA-1?

1.093

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.342

PA8240.2-2 ug/mL PA-824?

-0.522

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.509

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.367

Verapamil50 uM Verapamil?

0.456

mercaptoethanol2 mM 2-Mercaptoethanol?

0.304

methoxatin10-20 ug/mL Methoxatin?